Stock EVT EVOTEC SE
Add to a list
To use this feature you must be a member
Log inSign up

News Evotec SE

Equities

EVT

DE0005664809

Real-time Estimate Tradegate
Other stock markets
 06:53:21 2024-04-18 am EDT 		5-day change 1st Jan Change
13.2 EUR -0.11% Intraday chart for Evotec SE -1.58% -38.49%
Apr. 17 Evotec Names First Chief People Officer MT
Apr. 17 Evotec SE Welcomes Aurélie Dalbiez as Chief People Officer, Effective 15 June 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evotec SE to announce results for fiscal year 2023 on 24 April 2024
EQ
Evotec Names First Chief People Officer
MT
Evotec SE Welcomes Aurélie Dalbiez as Chief People Officer, Effective 15 June 2024
CI
Evotec welcomes Aurélie Dalbiez as Chief People Officer
EQ
AFR: Evotec SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQ
AFR: Evotec SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Deutsche Bank raises Evotec to 'Buy' - Frustration after CEO departure overcome
DP
STOXX 600 climbs over 1% on rate-cut optimism
RE
Deutsche Bank Research raises Evotec to 'Buy' - Target 19 Euro
DP
EVOTEC : Deutsche Bank takes a positive view
ZD
U.S. Futures, European Stocks Up as ECB Signals Moving Closer to Rate Cut
DJ
Evotec : Company Presentatio
PU
Evotec : Unternehmenspräsentation(englisch
PU
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
EVOTEC : Receives a Buy rating from Jefferies
ZD
Aeovian Pharmaceuticals, Inc. announced that it has received $50 million in funding from Sofinnova Investment, Inc., Evotec SE, venBio LLC, Apollo Health Ventures, b2venture AG, Hevolution Foundation
CI
Aeovian Pharmaceuticals, Inc. announced that it has received $50 million in funding from Hevolution Foundation, Apollo Health Ventures, Sofinnova Investment, Inc., venBio LLC, Evotec SE, b2venture AG
CI
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Evotec : Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
PU
Tubulis Technologies announced that it has received ?128 million in funding from a group of investors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EVT Stock
  4. News Evotec SE